BOLTON SECURITIES CORPORATION’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.1K Buy
886
+46
+5% +$627 ﹤0.01% 1752
2026
Q2
$11.4K Buy
840
+3
+0.4% +$36 ﹤0.01% 1768
2026
Q1
$5.02K Sell
837
-20
-2% -$150 ﹤0.01% 1760
2025
Q4
$6.15K Buy
857
+20
+2% +$158 ﹤0.01% 1705
2025
Q3
$8.94K Buy
837
+81
+11% +$795 ﹤0.01% 1574
2025
Q2
$7.32K Sell
756
-100
-12% -$1.03K ﹤0.01% 1564
2025
Q1
$12.8K Buy
+856
New +$13.2K ﹤0.01% 1382

Other funds holding OGN

BOLTON SECURITIES CORPORATION's OGN Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Organon & Co (OGN) stake by 5.5% in Q3 2026, buying an estimated $627 and bringing the position to 886 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

BOLTON SECURITIES CORPORATION first reported a position in OGN in Q1 2025 and has held it in 7 quarters since. The position peaked at $12.8K in Q1 2025. 507 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 886 shares of Organon & Co worth $12.1K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 46 Organon & Co shares in Q3 2026, an estimated $627.
  • Organon & Co made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1752 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Organon & Co in Q1 2025 and has held it in 7 quarters since.
  • BOLTON SECURITIES CORPORATION's Organon & Co position peaked at $12.8K in Q1 2025.
  • 507 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.